Bibliographic information

GuidelineGuidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children: recommendations for a public health approach: December 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection
Year of Publication2014
Issuing InstitutionWorld Health Organization

Recommendation

Maintained

Co-trimoxazole prophylaxis is recommended for HIV-exposed infants from 4–6 weeks of age and should be continued until HIV infection has been excluded by an age-appropriate HIV test to establish final diagnosis after complete cessation of breastfeeding.

Recommended in favor

Strong

Also Featured In

This recommendation also appears in the following guidelines:

Originally Developed
Guideline

WHO policy on collaborative TB/HIV activities : guidelines for national programmes and other stakeholders

Year2012
InstitutionWHO
Guideline

Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach

Year2016
InstitutionWHO
Guideline

Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach

Year2016
InstitutionWHO
Guideline

Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

Year2021
InstitutionWHO
Guideline

Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

Year2021
InstitutionWHO
Guideline

WHO guidelines on the management of advanced HIV disease

Year2025
InstitutionWorld Health Organization